Results of the reader study comparing frequencies of optimal management decisions ( f ) of 89 dermatologists by diagnosis without AI support (-AI), with support by the SL model (+SL) and with support by the RL model (+RL). Optimal managements: 'excision' for melanomas and basal cell carcinomas; 'local therapy' for actinic keratoses/intraepidermal carcinoma; and 'dismiss' for nevi, benign keratinocytic lesions, dermatofibroma and vascular lesions. Bars, means; whiskers, standard error. Sample sizes: MEL(-AI): n = 89; MEL(+SL): n = 78; MEL(+RL): n = 81; BCC(-AI): n = 89; BCC(+SL): n = 63; BCC(+RL): n = 68; AKIEC(-AI): n = 89; AKIEC(+SL): n = 60; AKIEC(+RL): n = 72; NV(-AI): n = 89; NV(+SL): n = 88; NV(+RL): n = 85; BKL(-AI): n = 89; BKL(+SL): n = 65; BKL(+RL): n = 76; DF(-AI): n = 89; DF(+SL): n = 71; DF(+RL): n = 61; VASC(-AI): n = 89, VASC(+SL): n = 67; VASC(+RL): n = 65. Abbreviations: MEL, melanoma; BCC, basal cell carcinoma; AKIEC, actinic keratosis/intraepidermal carcinoma; BKL, benign keratinocytic lesion; NV, melanocytic nevus; DF, dermatofibroma; VASC, vascular lesion.
